Major Zantac Seller Down $186M Amidst Lawsuits

February 17, 2020 – Sanofi has taken a $186 million write-off for Zantac after recalling it back in October 2019. The following companies have now recalled a version of Zantac:

• Sanofi
• Golden State Medical Supply
• Novitium Pharma
• Amneal
• Northwind Pharmaceuticals (a.k.a. Denton Pharma)
• Sandoz (pharma division of Novartis)
• Appco Pharma
• Apotex
• Perrigo
• Lannett Company
• Aurobindo

Also, Walgreens and CVS have stopped selling Zantac.

Reference: Blankenship, Kyle. “Sanofi Takes $186M Hit on the Heels of Zantac Recall.” Fierce Pharma, 06 Feb. 2020, https://www.fiercepharma.com/manufacturing/sanofi-takes-a-big-financial-hit-after-recall-contaminated-zantac;

www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/2019_Q4_Press_Release_EN.pdf.